← Leaderboards
Daniel Botelho Costa
Beth Israel Deaconess Medical Center
$3,158,732
Attributed
$3,158,732
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $523.5K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,158,732 · 2
By mechanism
R37$2,789,835 · 1
P50$368,897 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Fredric E. Wondisford$29,129,494
- Susumu Kobayashi$5,296,351
- Frank J. Slack$24,707,497
- Albert Mark Galaburda$4,480,643
- Christopher A Walsh$66,138,888
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorMalignant Neoplasm Of LungBiologyDoseCombined Modality TherapyAntibodiesCohortAdenosine KinaseClinical TrialsAffinityAmino AcidsAdenosine TriphosphateBindingClinical DevelopmentAntitumor EffectClinical EfficacyCancer EtiologyCancer TherapyApoptoticCell DeathCell LineCessation Of LifeClinical CareCollection
Grant awards (10)
Career Enhancement Program$110,204
P50 · FY2025 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$384,536
R37 · FY2024 · CA · contact PI
Career Enhancement Program$131,889
P50 · FY2024 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$396,679
R37 · FY2023 · CA · contact PI
Career Enhancement Program$126,804
P50 · FY2023 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$400,518
R37 · FY2022 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$400,518
R37 · FY2021 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$401,678
R37 · FY2020 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$396,735
R37 · FY2019 · CA · contact PI
Unmet needs for specific subsets of EGFR mutated lung cancer$409,171
R37 · FY2018 · CA · contact PI